P1738COULD ADDING BORTEZOMIB HAVE BENEFIT FOR ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION?
Dalili, Nooshin, Nafar, MohsenVolume:
35
Journal:
Nephrology Dialysis Transplantation
DOI:
10.1093/ndt/gfaa142.p1738
Date:
June, 2020
File:
PDF, 84 KB
2020